Detail akcie GE Hltc Tech Rg-WI online

Business Summary: GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, GE HealthCare Technologies Inc revenues increased 5% to $20.63B. Net income increased 5% to $2.08B. Revenues reflect Total PDx segment increase of 16% to $2.9B, Total Imaging segment increase of 4% to $9.25B, United States segment increase of 6% to $9.17B, Other segment increase of 6% to $9.43B. Net income also reflects Interest and other financial charges - n decrease of 13% to $440M (expense).